<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Palatino;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:470096116;
mso-list-type:hybrid;
mso-list-template-ids:-629382456 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l1
{mso-list-id:476336646;
mso-list-type:hybrid;
mso-list-template-ids:-634473710 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l2
{mso-list-id:1531532262;
mso-list-template-ids:-1274142162;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l2:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level4
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level5
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level7
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level8
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://anr.rwjf.org/viewCfp.do?cfpId=1459&cfpOverviewId=__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDXAQREKo$" target="_blank">Robert Wood Johnson Foundation: Health Care’s Role in Meeting Patients’ Needs</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The purpose of this call for proposals is to identify grantees who can lead an effort to provide: <br>
<b>Part I: Clear Principles </b>that set a high standard for the health care sector to provide equitable care that fully addresses people’s physical, emotional, and social needs; and <br>
<b>Part II: Guidance</b> for implementing care delivery that is fully responsive to patients’ goals, needs, and life circumstances, using maternal morbidity and mortality as a case example. <br>
We expect that these component parts may be led by separate organizations and we invite applicants to apply to lead either one or both component parts. The goals of the program are to:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l0 level1 lfo1"><span style="font-size:12.0pt;font-family:Palatino">Use evidence and engagement to articulate a set of principles describing bold aspirations for the health care sector to be responsive to patients’ goals,
needs, and life circumstances, along the full spectrum of population health improvement activities. These principles should be supported by a set of clear, tested messages that resonate with audiences we aim to reach and influence (Part I, Clear Principles);<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l0 level1 lfo1"><span style="font-size:12.0pt;font-family:Palatino">Demonstrate—with concrete examples, and using the principles identified in Part I—how health care can and should help the people they serve live their
healthiest lives, with a focus on making change within health care delivery systems (Part II, Guidance); <o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l0 level1 lfo1"><span style="font-size:12.0pt;font-family:Palatino">Identify and execute communications strategies targeted to health care leaders and stakeholders (Parts I and II, Clear Principles and Guidance).<o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">$2-3M (depending on Part applied for) for two-year projects.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Brief proposals due August 15, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: August 1, 2019.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.american-hearing.org/research-grants/grants-we-offer/__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDUrTsX-Y$" target="_blank">American Hearing Health Foundation: Meniere’s Disease Research</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Through this program, grants of up to $25,000 will be awarded in support of research on the causes, diagnosis, and/or treatment of Meniere’s disease, with a focus on the hearing or balance
functions of the ear. Basic and clinical studies that investigate aspects of the auditory and vestibular systems, including but not limited to genetics, neurotology, anatomy, auditory processing, molecular and cellular biology, therapeutic studies, and investigations
of current or experimental devices (i.e., cochlear implants), may be proposed.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due August 15, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: August 1, 2019.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.american-hearing.org/research-grants/grants-we-offer/__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDUrTsX-Y$" target="_blank">American Hearing Research Foundation Grants: Hearing and Balance Disorders of the Inner Ear
and Related Topics</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Through this program, six to ten grants of up to $50,000 each will be awarded in support of research on various aspects of hearing and balance disorders related to the inner ear. Both
basic and clinical research that investigates aspects of the auditory and vestibular systems, including but not limited to genetics, neurotology, anatomy, auditory processing, molecular and cellular biology, therapeutic studies, and investigations of current
or experimental devices (i.e., cochlear implants), may be proposed. Priority will be given to investigators early in their careers who need seed funding to generate results and data that can be used to support applications for larger grants (i.e., NIH) in
the future.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due August 15, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: August 1, 2019.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:red"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__http://www.steveandalex.org/wp-content/uploads/2019/07/Cohen-Lyme-TBD-RFP-Research-2019-06-28.pdf__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDACq1bik$" target="_blank">Steven & Alexandra Cohen Foundation: Lyme and Tickborne Disease
Initiative</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The foundation is requesting new proposals in the following areas: diagnostics for Lyme and other tickborne diseases; pathogenesis of post-treatment Lyme disease syndrome (PTLDS) and/or
persistent symptoms after confirmed or suspected Lyme disease; pathogenesis of co-infection /co-morbidity; pathogenesis of other tickborne disease; therapeutic development for tickborne disease; economic analysis of Lyme and tickborne disease diagnosis and
treatment; and support for new/emerging researchers or clinicians. Grants will support discrete, time-bound projects over a period of one to four years. After a scientific review, the foundation will announce its funding decisions between September 15 and
October 15. Projects requesting more than $300,000 in any year will receive additional financial review.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due August 15, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: August 1, 2019.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__http://www.russellsage.org/funding/decision-making-and-human-behavior-context__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDreFSvIQ$" target="_blank">Russell Sage Foundation: Decision Making and Human Behavior in Context
</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">This initiative will support innovative research on decision making across the social sciences that examines causes, consequences, processes, or context from a behavioral or alternative
perspective. We seek to support a wide range of research on decision-making in context by scholars in psychology, political science, sociology, and other social science fields who are pursuing questions consistent with the aims of the Foundation.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">This initiative will support research proposals from multiple methodological perspectives that will further our understanding of decision making processes and human behavior in the contexts
of work, race, ethnicity, immigration, and social inequality, broadly conceived, in the U.S. Priority will be given to research related to our
<a href="https://urldefense.com/v3/__http://www.russellsage.org/programs__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDpC4k01k$">core programs</a> and other <a href="https://urldefense.com/v3/__http://www.russellsage.org/special-initiatives__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDLLcbn9w$">
special initiatives</a>. Limited consideration will be given to projects that test well-established behavioral effects without examining the overarching context or the underlying mechanisms. RSF is open to a range of questions consistent with its mission, and
has a particular interest in the following research areas:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l1 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Biases and Misperceptions<b><o:p></o:p></b></span></li><li class="MsoNormal" style="mso-list:l1 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Motivations and Incentives<b><o:p></o:p></b></span></li><li class="MsoNormal" style="mso-list:l1 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Habits and Behavior Change<b><o:p></o:p></b></span></li><li class="MsoNormal" style="mso-list:l1 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Affect and Emotions<b><o:p></o:p></b></span></li><li class="MsoNormal" style="mso-list:l1 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Networks and Contexts<b><o:p></o:p></b></span></li></ul>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Letter of inquiry due August 19, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: August 5, 2019.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://pardeefoundation.org/how-to-apply/__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDRg4bNr8$" target="_blank">Elsa U. Pardee Foundation: Cancer Research Grants</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The Elsa U. Pardee Foundation funds research to investigators in United States non-profit institutions proposing research directed toward identifying new treatments or cures for cancer.
The Foundation particularly encourages grant applications for a one year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding
by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. By design, there are no limits set on the grant amount that can be requested.
It must be reasonably and clearly supported by the scope of the project outlined in the application.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due August 31 and December 31, 2019.
<span style="color:red">Med-RA deadline to receive draft documents for August deadline: August 16, 2019.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__http://amyloidosis.org/research/*grant-programs__;Iw!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDIDm274M$" target="_blank">Amyloidosis Foundation Research Grants</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The Amyloidosis Foundation focuses on raising awareness in the medical field of amyloidosis, a group of diseases in which abnormal protein, known as amyloid fibrils, builds up in tissue;
educating medical professionals through its Grand Rounds program and attendance at medical conferences; prioritizing a research agenda through grants and partnership with the Amyloidosis Research Consortium; and empowering patients through its comprehensive
range of services, including accurate, up-to-date information. To that end, the foundation will award grants of up to $50,000 in support of basic biomedical and clinical research related to systemic amyloidosis. To be eligible, applicants must be within ten
years of completion of their postdoctoral studies or clinical fellowship and have a mentor.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due September 13, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: August 30, 2019.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimer’s Disease (R21 / R01 Clinical Trial Not Allowed)<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-041.html__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDgNuutrc$" target="_blank">R21</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">This Funding Opportunity Announcement (FOA) invites early stage innovative and exploratory research focusing on understanding the regulation of brain regional and cell type-specific protein
dynamics in Alzheimer's disease (AD). In particular, this FOA seeks applications proposing to develop novel proteomic platforms and animal models to further understanding of the alteration of a single-cell neuronal cell proteome in the central nervous system
(CNS) during the course of aging and AD.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-042.html__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDWW_7y80$" target="_blank">R01</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">This FOA invites innovative research focused on understanding the regulation of brain regional and cell-type-specific proteome dynamics in AD. Specifically, this FOA encourages collaborative
approaches to design and implement novel, single-cell-based proteomic platforms to comprehensively characterize the dynamics of neuronal proteomes during the course of aging and AD.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due October 23, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: October 9, 2019.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:red"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.com/v3/__https://www.idsafoundation.org/alz-research-grant/__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXDsdD7UPk$" target="_blank">Infectious Diseases Society of America Foundation: Alzheimer’s Research Grant</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">Alzheimer’s disease is devastating for the 47 million people worldwide living with the disease, robbing them of memories and the ability to function independently. Researchers
have long sought the cause and worked to develop a cure, without significant success.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">Some evidence suggests that Alzheimer’s may be triggered or driven by an infectious agent or microbial mechanism. Could this be the missing link to lead to a cure for Alzheimer’s
disease?<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">Determined to advance science regarding this possible connection, the IDSA Foundation is offering up to five one-time, $100,000 grants to researchers working to identify a
microbial link to Alzheimer’s disease.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">The IDSA Foundation research grants are designed to:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="color:black;mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Obtain evidence that an infectious agent or microbial community is correlated to Alzheimer’s disease<o:p></o:p></span></li><li class="MsoNormal" style="color:black;mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Promote novel research in the field of microbial triggers for Alzheimer’s disease<o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino;color:black">To be eligible for a grant, research must be narrowly focused on identifying the possible role of an infectious agent or agents in causing Alzheimer’s disease. Awards will
support innovative research, including basic, clinical and/or non-traditional approaches.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">Due November 30, 2019.
</span></b><b><span style="font-size:12.0pt;font-family:Palatino;color:red">Med-RA deadline to receive draft documents: November 13, 2019.</span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.acog.org/About-ACOG/ACOG-Departments/Awards-and-Professional-Recognition/Research?IsMobileSet=false__;!5Xm4_O-4tfk!nDkxQADoKTVmS8KrBnWCKItYVpoyk_Rl1yKNWsfl1JjA-5lxaHaspL5RSVQyEBf9VVg_fw-UxAXD8Y_z8NQ$" target="_blank">American Congress of Obstetricians and Gynecologists
Warren H. Pearse Women's Health Policy Research Award</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">This research award will provide $10,000 to support research that explores an aspect of health care policy that assists, defines, or restricts the ability of a physician to deliver health
care to women in the general population, or in a specific area.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due December 11, 2019.
<span style="color:red">Med-RA deadline to receive draft documents: November 22, 2019.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">To search for additional funding opportunities, please visit </span></b><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=" title="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV69"><b><span style="color:red">CoM’s
unofficial funding opportunities blog</span></b></a><b><span style="color:red">.</span></b><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>